Maxiphen - 58605-422-01 - (GUAIFENESIN and Phenylephrine Hydrochloride)

Alphabetical Index


Drug Information of Maxiphen

Product NDC: 58605-422
Proprietary Name: Maxiphen
Non Proprietary Name: GUAIFENESIN and Phenylephrine Hydrochloride
Active Ingredient(s): 400; 10    mg/1; mg/1 & nbsp;   GUAIFENESIN and Phenylephrine Hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Maxiphen

Product NDC: 58605-422
Labeler Name: MCR American Pharmaceuticals, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number: part341
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date: 20080331

Package Information of Maxiphen

Package NDC: 58605-422-01
Package Description: 100 TABLET in 1 BOTTLE, PLASTIC (58605-422-01)

NDC Information of Maxiphen

NDC Code 58605-422-01
Proprietary Name Maxiphen
Package Description 100 TABLET in 1 BOTTLE, PLASTIC (58605-422-01)
Product NDC 58605-422
Product Type Name HUMAN OTC DRUG
Non Proprietary Name GUAIFENESIN and Phenylephrine Hydrochloride
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20080331
Marketing Category Name OTC MONOGRAPH FINAL
Labeler Name MCR American Pharmaceuticals, Inc.
Substance Name GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
Strength Number 400; 10
Strength Unit mg/1; mg/1
Pharmaceutical Classes

Complete Information of Maxiphen


General Information